Dr. Bárbara Rivera receives the support of the Mutua Madrileña Foundation to investigate a rare childhood disease


The Mutua Madrileña Foundation, on its XVII Health Research Grants, has destined 2.3 million euros to medical research in Spain. Yesterday the 21 projects selected to receive funding were announced, including four Catalan projects that will receive total funding of more than 540,000 euros.

Dr. Bárbara Rivera, Principal Investigator of the Bellvitge Biomedical Research Institute (IDIBELL) in the Hereditary Cancer group of the Oncobell program, and Associate Professor at McGill University in Montreal, has received funding to study rare diseases affecting childhood. In particular, Dr. Rivera will analyze the profile of thyroid alterations in syndromes associated with mutations in genes involved in microRNA biogenesis.

The objective of the Mutua Madrileña Foundation with this annual grant program is to improve medical treatments and contribute to the maintenance and development of scientific research. The Scientific Committee of the Mutua Madrileña Foundation is chaired by Dr. Rafael Matesanz and formed by Professor Miguel Caínzos, Professor Antonio Torres, Professor Ana Lluch, and Professor Fernando Marco.

Scroll to Top